Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure — NEJM

Retweeted NEJM (@NEJM): RED-HF: Darbepoetin alfa didn’t improve clinical outcomes in systolic HF and mild-to-moderate anemia. http://t.co/5pZIpjPWUi #ACC13

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/5pZIpjPWUi